TGFB1 Antikörper (Dimer)
Kurzübersicht für TGFB1 Antikörper (Dimer) (ABIN199715)
Target
Alle TGFB1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- Dimer
-
Spezifität
- Recognizes the dimeric (25kD) and monomeric (12.5kD.) forms of TGF-beta in Western Blot under non-reducing and reducing conditions, respectively. Recognizes both human platelet-derived and recombinant TGF-beta in ELISA.
-
Aufreinigung
- Protein G purified
-
Immunogen
-
TGF B from human platelets.
Type of Immunogen: Purified protein -
Isotyp
- IgG1 kappa
-
-
-
-
Applikationshinweise
-
Approved: ELISA, WB
Usage: Suitable for use in Western Blot and ELISA. Western Blot: 5-20 ng/mL will allow visualization of 100 ng/lane of TGF-beta. Hybridoma: Sp2/0-Ag14 myeloma cells with spleen cells from Balb/c mice. -
Kommentare
-
Target Species of Antibody: Human
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- Lot specific
-
Buffer
- From 0.01 M PBS, pH 7.0, 40 % glycerol.
-
Handhabung
- Avoid repeat freeze-thaw cycles.
-
Lagerung
- 4 °C,-20 °C
-
Informationen zur Lagerung
- Short term: 4°C. Long term: Store at -20°C. Avoid freeze-thaw cycles.
-
-
- TGFB1 (Transforming Growth Factor, beta 1 (TGFB1))
-
Andere Bezeichnung
- TGFB1 / TGF Beta 1
-
Hintergrund
-
Name/Gene ID: TGFB1
Family: TGF beta
Synonyms: TGFB1, CED, DPD1, Diaphyseal dysplasia 1, LAP, Latency-associated peptide, TGF Beta, TGFbeta, TGF-beta 1 protein, TGF-beta-1, TGFB -
Gen-ID
- 7040
-
UniProt
- P01137
-
Pathways
- EGFR Signaling Pathway, Dopaminergic Neurogenesis, Cellular Response to Molecule of Bacterial Origin, Glycosaminoglycan Metabolic Process, Regulation of Leukocyte Mediated Immunity, Regulation of Muscle Cell Differentiation, Positive Regulation of Immune Effector Process, Cell-Cell Junction Organization, Production of Molecular Mediator of Immune Response, Ribonucleoside Biosynthetic Process, Skeletal Muscle Fiber Development, Regulation of Carbohydrate Metabolic Process, Protein targeting to Nucleus, Autophagie, Cancer Immune Checkpoints
Target
-